Measuring the C-reactive protein (CRP) level in patients admitted with ST-segment elevation acute myocardial infarction (MI) may be useful in predicting whether thrombolytic therapy will be successful, according to a recent report.
Furthermore, such levels appear to correlate with short- and long-term cardiac mortality, Dr. Michael Zairis and colleagues, from Tzanio Hospital in Piraeus, Greece, note in the November issue of the American Heart Journal.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!